可靶向的分泌型神经蛋白驱动胰腺癌转移定植与HIF1α核滞留
研究在人和小鼠胰腺导管腺癌细胞中发现,分泌型神经五聚蛋白1(NPTX1)在转移进展中过表达,其受体为含Ig样结构域黏附分子2(AMIGO2);NPTX1-AMIGO2信号促进缺氧生长并是HIF1α核滞留与功能所必需,高亲和力单克隆抗体靶向NPTX1可大幅减少肝转移定植。
要点
- NPTX1在人和小鼠PDAC转移进展中过表达,并在人PDAC肿瘤及肝转移中上调。
- 分泌型NPTX1以细胞自主方式作用于AMIGO2受体,驱动PDAC肝转移定植。
- NPTX1-AMIGO2信号增强缺氧生长,为HIF1α核滞留与功能所必需。
核心结论
- NPTX1-AMIGO2是PDAC中HIF1α缺氧反应的可成药关键上游调控轴。
研究设计与样本
- 采用分子、遗传、生化与药理学实验,在人及小鼠PDAC细胞中鉴定NPTX1及其受体AMIGO2。
主要发现
- NPTX1在人和小鼠PDAC细胞转移进展中过表达,并在人PDAC肿瘤及肝转移中上调。
- 分泌型NPTX1以细胞自主方式作用于AMIGO2受体,驱动PDAC肝转移定植。
- NPTX1-AMIGO2信号增强缺氧生长,并为HIF1α核滞留与功能所必需。
- 高亲和力单克隆抗体靶向NPTX1大幅减少PDAC肝转移定植。
临床怎么用
- 临床前模型中,靶向NPTX1在抑制肝转移方面优于一种常用化疗方案,并抑制原发肿瘤生长。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pancreatic ductal adenocarcinoma (PDAC) is an increasingly diagnosed cancer that kills 90% of afflicted patients, with most patients receiving palliative chemotherapy. We identified neuronal pentraxin 1 (NPTX1) as a cancer-secreted protein that becomes overexpressed in human and murine PDAC cells during metastatic progression and identified adhesion molecule with Ig-like domain 2 (AMIGO2) as its receptor. Molecular, genetic, biochemical, and pharmacologic experiments revealed that secreted NPTX1 acts cell-autonomously on the AMIGO2 receptor to drive PDAC metastatic colonization of the liver-the primary site of PDAC metastasis. NPTX1-AMIGO2 signaling enhanced hypoxic growth and was critically required for hypoxia-inducible factor-1α (HIF1α) nuclear retention and function. NPTX1 is overexpressed in human PDAC tumors and upregulated in liver metastases. Therapeutic targeting of NPTX1 with a high-affinity monoclonal antibody substantially reduced PDAC liver metastatic colonization. We thus identify NPTX1-AMIGO2 as druggable critical upstream regulators of the HIF1α hypoxic response in PDAC. Significance: We identified the NPTX1-AMIGO2 axis as a regulatory mechanism upstream of HIF1α-driven hypoxia response that promotes PDAC liver metastasis. Therapeutic NPTX1 targeting outperformed a common chemotherapy regimen in inhibiting liver metastasis and suppressed primary tumor growth in preclinical models, revealing a novel therapeutic strategy targeting hypoxic response in PDAC.
引用
- Yamaguchi N, Wu YG, Ravetch E, et al. A Targetable Secreted Neural Protein Drives Pancreatic Cancer Metastatic Colonization and HIF1α Nuclear Retention. Cancer Discov. 2024. PMID: 39028915. doi:10.1158/2159-8290.CD-23-1323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。